A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Emerging infectious diseases are newly identified diseases or diseases that have recently expanded in range, host breadth, or incidence. More than 60% are zoonoses — diseases transmitted from animals to humans via spillover events driven by land use change, wildlife trade, and deforestation that bring humans into novel contact with animal reservoirs. RNA virus mutation rates and genomic reassortment (in segmented viruses like influenza) generate new strains capable of human adaptation. The One Health framework recognizes that human, animal, and environmental health are inseparably linked, and pandemic preparedness requires integrated surveillance at the human-animal-environment interface. HIV (from chimpanzee SIVcpz), SARS-CoV, SARS-CoV-2, Ebola, and Nipah illustrate recurring spillover patterns.
Trace the spillover and emergence history of HIV — phylogenetic reconstruction linking it to SIVcpz, the colonial-era conditions enabling spread, and the decades of cryptic transmission before recognition. Then apply the same spillover framework to SARS-CoV-2, comparing what was and was not predictable, and what surveillance gaps allowed the pandemic to unfold.
From your study of infectious disease epidemiology, you understand how pathogens spread through populations and how we measure and model transmission. Emerging infectious diseases (EIDs) are the subset of infectious diseases that are either entirely new to humans, have recently expanded their geographic range or host species, or have dramatically increased in incidence. They represent the leading edge of the ongoing evolutionary contest between microbes and their hosts — and understanding why they emerge requires integrating virology, ecology, and public health in ways that no single discipline can accomplish alone.
The most important pattern in emergence is zoonotic spillover: the majority of new human infections originate in animal reservoirs. HIV crossed from chimpanzees, SARS-CoV and SARS-CoV-2 likely originated in bats (with possible intermediate hosts), Ebola circulates in bat populations in central Africa, and Nipah virus spills over from fruit bats in South and Southeast Asia. These are not random events. Spillover is driven by ecological disruption — deforestation, agricultural expansion, wildlife trade, and urbanization push humans into closer contact with animals harboring viruses to which we have no immunity. The frequency of spillover events is increasing precisely because these ecological pressures are intensifying globally.
Once a pathogen enters a human host, whether it causes a limited outbreak or a global pandemic depends on its capacity for sustained human-to-human transmission. RNA viruses are disproportionately represented among emerging pathogens because their error-prone polymerases (which you studied in viral replication) generate high mutation rates, producing the genetic variation on which natural selection can act. Influenza adds another mechanism — genomic reassortment — where co-infection of a single cell with two different influenza strains can shuffle genome segments to produce entirely novel combinations, as occurred in the 1918, 1957, 1968, and 2009 pandemics. A virus that adapts to transmit efficiently via respiratory droplets, has a presymptomatic infectious period (allowing carriers to spread it before they feel sick), and encounters an immunologically naive population has all the ingredients for pandemic spread.
The One Health framework responds to these realities by insisting that human health, animal health, and environmental health are inseparable. Surveillance systems that monitor wildlife populations for novel viruses, that track antibiotic resistance in agricultural settings, and that detect unusual disease clusters in human communities are all necessary components of preparedness. The lesson of recent pandemics is not that emergence is unpredictable — in fact, scientists had warned about coronavirus pandemic potential for years before SARS-CoV-2 — but that the gap between scientific warning and institutional response remains dangerously wide. Effective preparedness requires standing diagnostic infrastructure (platforms that can rapidly develop tests for novel pathogens), genomic surveillance networks (to detect and track variants in real time), and public health systems capable of implementing containment measures before exponential growth makes them futile.